Capital Research Global Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-425,160
| Closed | -$35.8M | – | 453 |
|
|
2021
Q4 | $35.8M | Sell |
425,160
-2,936,632
| -87% | -$247M | 0.01% | 390 |
|
|
2021
Q3 | $303M | Sell |
3,361,792
-1,207,013
| -26% | -$109M | 0.07% | 212 |
|
|
2021
Q2 | $436M | Sell |
4,568,805
-2,805,068
| -38% | -$267M | 0.1% | 179 |
|
|
2021
Q1 | $840M | Buy |
7,373,873
+111,972
| +2% | +$12.7M | 0.21% | 113 |
|
|
2020
Q4 | $1.01B | Buy |
7,261,901
+477,833
| +7% | +$66.1M | 0.26% | 94 |
|
|
2020
Q3 | $558M | Buy |
6,784,068
+4,503
| +0.1% | +$370K | 0.17% | 129 |
|
|
2020
Q2 | $530M | Buy |
6,779,565
+205,605
| +3% | +$16.1M | 0.17% | 127 |
|
|
2020
Q1 | $292M | Buy |
6,573,960
+211,265
| +3% | +$9.39M | 0.11% | 148 |
|
|
2019
Q4 | $272M | Buy |
6,362,695
+5,514
| +0.1% | +$236K | 0.08% | 194 |
|
|
2019
Q3 | $272M | Buy |
6,357,181
+55
| +0% | +$2.35K | 0.09% | 182 |
|
|
2019
Q2 | $404M | Buy |
6,357,126
+1,694
| +0% | +$108K | 0.13% | 148 |
|
|
2019
Q1 | $441M | Buy |
6,355,432
+499,277
| +9% | +$34.6M | 0.14% | 145 |
|
|
2018
Q4 | $255M | Buy |
5,856,155
+17
| +0% | +$739 | 0.09% | 180 |
|
|
2018
Q3 | $447M | Buy |
5,856,138
+100,575
| +2% | +$7.68M | 0.13% | 146 |
|
|
2018
Q2 | $442M | Sell |
5,755,563
-158,884
| -3% | -$12.2M | 0.12% | 145 |
|
|
2018
Q1 | $302M | Buy |
5,914,447
+929,442
| +19% | +$47.4M | 0.09% | 193 |
|
|
2017
Q4 | $231M | Buy |
4,985,005
+895,266
| +22% | +$41.5M | 0.07% | 217 |
|
|
2017
Q3 | $218M | Sell |
4,089,739
-1,093,591
| -21% | -$58.2M | 0.07% | 218 |
|
|
2017
Q2 | $322M | Buy |
5,183,330
+71,811
| +1% | +$4.46M | 0.1% | 173 |
|
|
2017
Q1 | $346M | Buy |
5,111,519
+106,660
| +2% | +$7.23M | 0.11% | 175 |
|
|
2016
Q4 | $352M | Buy |
5,004,859
+174,000
| +4% | +$12.2M | 0.11% | 172 |
|
|
2016
Q3 | $343M | Buy |
4,830,859
+52,690
| +1% | +$3.74M | 0.11% | 173 |
|
|
2016
Q2 | $234M | Buy |
4,778,169
+11,696
| +0.2% | +$572K | 0.08% | 205 |
|
|
2016
Q1 | $302M | Buy |
4,766,473
+10,000
| +0.2% | +$633K | 0.1% | 181 |
|
|
2015
Q4 | $534M | Buy |
4,756,473
+17,962
| +0.4% | +$2.01M | 0.18% | 123 |
|
|
2015
Q3 | $456M | Buy |
4,738,511
+340,443
| +8% | +$32.8M | 0.16% | 139 |
|
|
2015
Q2 | $450M | Buy |
4,398,068
+122,982
| +3% | +$12.6M | 0.15% | 156 |
|
|
2015
Q1 | $265M | Buy |
4,275,086
+367,500
| +9% | +$22.8M | 0.09% | 217 |
|
|
2014
Q4 | $171M | Buy |
3,907,586
+81,310
| +2% | +$3.57M | 0.06% | 252 |
|
|
2014
Q3 | $217M | Buy |
3,826,276
+1,763,100
| +85% | +$99.8M | 0.08% | 222 |
|
|
2014
Q2 | $86.6M | Hold |
2,063,176
| – | – | 0.03% | 302 |
|
|
2014
Q1 | $89.9M | Buy |
+2,063,176
| New | +$89.9M | 0.03% | 292 |
|